New Delhi [India], January 3 : The National Centre for Disease Control (NCDC), under the Union Health Ministry, is closely monitoring the rise in respiratory and seasonal influenza cases across India, according to official sources. The Ministry is also in contact with international agencies to stay updated on developments.
“We will continue to monitor the situation, validate information, and provide updates as necessary,” said sources.
This comes in response to reports of an outbreak of Human Metapneumovirus (HMPV) in China. Between December 16 and 22, data showed an increase in acute respiratory infections, including seasonal influenza, rhinovirus, respiratory syncytial virus (RSV), and HMPV. However, the overall scale of respiratory infections in China this year is reportedly lower than last year’s figures. A seasonal surge in respiratory diseases is expected in the northern hemisphere during the winter months, sources added, based on an update from the World Health Organization’s Western Pacific Regional Office (WPRO).
Dr. Arjun Dang, CEO of Dr. Dang’s Lab, emphasized the need for heightened surveillance and early detection in light of the outbreak in China. He described HMPV as an under-recognized pathogen that has contributed to seasonal respiratory illnesses globally, particularly in vulnerable populations such as young children, the elderly, and individuals with weakened immune systems.
“The resurgence of HMPV underscores the challenges respiratory viruses pose, particularly in densely populated areas. We have routinely reported HMPV cases during flu seasons, and its spread can strain healthcare systems if not promptly controlled,” Dr. Dang explained.
HMPV symptoms often resemble those of other respiratory viruses, including fever, cough, nasal congestion, shortness of breath, and wheezing. Severe cases can lead to bronchiolitis or pneumonia, particularly in high-risk groups. Dr. Dang stressed that without rapid intervention, the burden on healthcare infrastructure could become significant.
According to Dr. Dang, Polymerase Chain Reaction (PCR) testing remains the gold standard for diagnosing HMPV, and there is no specific antiviral treatment available. He emphasized the importance of prevention in curbing the virus’s spread, including regular hand washing, covering the mouth when coughing, and avoiding close contact with sick individuals.
“While there is no antiviral treatment for HMPV, management is supportive, focusing on hydration, fever control, and oxygen therapy for severe cases. Prevention through simple measures like hand hygiene, respiratory etiquette, and minimizing contact with symptomatic individuals can significantly reduce transmission. Authorities must launch public awareness campaigns to emphasize these preventative strategies,” Dr. Dang concluded.